| Filed On | Filing |
|---|---|
| 08 Oct 2019 |
Form 3: Lewis Dijuana K, Director
No securities owned |
| 13 Dec 2018 |
Form 3: Samet Kenneth A, Director
Holds 3,000 shares of Common Stock |
| 05 Mar 2018 |
Form 3: Shapiro Eric, SR VP, GLOBAL MARKETING
Holds 16,240 shares of Common Stock |
| 23 Feb 2018 |
Form 3: Collins Charles J., SR VP, R&D - US
Holds 28,856 shares of Common Stock |
| 06 Dec 2016 |
Form 3: Bennett Todd C., SVP, Global Sales & Cust Ops
Holds 8,334 shares of Common Stock |
| 06 Dec 2016 |
Form 3: Lazarus Tadd S., SVP, Chief Medical Officer
Holds 0 shares of Common Stock |
| 10 Mar 2016 |
Form 3: Eck Stephen L., Director
Holds 0 shares of Common Stock |
| 23 Mar 2015 |
Form 3: Myers Randall, SVP, Global Mfg and Quality
Holds 0 shares of Common Stock |
| 11 Mar 2015 |
Form 3: Rew Richard W. Ii, SVP, Gen Counsel & Corp Secy
Holds 0 shares of Common Stock |
| 12 Feb 2015 |
Form 3: Fairchild Nancy, Sr Vice President, HR
Holds 33,344 shares of Common Stock |
| 16 Oct 2014 |
Form 3: Shamir Nachum, Director
Holds 0 shares of Common Stock |
| 20 Sep 2010 |
Form 3: Dehne Timothy R, VP, Systems R&D
Holds 26,857 shares of COMMON STOCK |
| 06 Jul 2009 |
Form 3: Pintek Michael F, SVP Operations
No securities owned |
| 26 May 2009 |
Form 3: Ogunro Edward A, Director
No securities owned |
| 17 Jul 2007 |
Form 3: Bryant Douglas C, EVP, Chief Operating Officer
Holds 0 shares of COMMON STOCK |
| 07 Mar 2007 |
Form 3: Bridge-cook Jeremy K, VP, Luminex Molecular Diagn
Holds 0 shares of COMMON STOCK |
| 16 Feb 2007 |
Form 3: Carrano John C, VP, Research & Development
Holds 19,412 shares of COMMON STOCK |
| 31 May 2005 |
Form 3: Bradley Russell S, VP, Strategic Planning and Bus
No securities owned |
| 14 Feb 2005 |
Form 3: Johnston Jay B, Director
Holds 6,000 shares of Common Stock |
| 14 Feb 2005 |
Form 3: Vaillant Gerard, Director
No securities owned |
Loading...